Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Outcomes for patients with multiple myeloma (MM) have improved in recent years owing to use of novel agents and high-dose therapy followed by autologous stem cell transplant (ASCT). We analyzed the outcomes of 511 consecutive patients treated with novel therapies at our institution between 2006 and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Leukemia
Egile Nagusiak: Majithia, N, Rajkumar, SV, Lacy, MQ, Buadi, FK, Dispenzieri, A, Gertz, MA, Hayman, SR, Dingli, D, Kapoor, P, Hwa, L, Lust, JA, Russell, SJ, Go, RS, Kyle, RA, Kumar, SK
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541860/
https://ncbi.nlm.nih.gov/pubmed/27211270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.147
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak